Helen Heslop and colleagues conducted a phase 1 clinical trial involving 19 children with neuroblastoma, between 2004 and ...

Professor Helen Heslop, who led the trial, said: 'It's nice to have such long-term follow-up and to see that even if it was a very early CAR T-cell – and there's been a lot of work to make them ...

Among 19 neuroblastoma patients treated with CAR T-cell therapy, eight survived more than 5 years after infusion, including five with follow-up of more than 13 years, reported Helen Heslop ...

The $17 million will support cell therapy in adults and pediatric patients, Helen Heslop, director of the Center for Cell and Gene Therapy, said via news release. Additionally, Texas Southern ...